VVOS Vivos Therapeutics, Inc.

NASDAQ
$0.08

Vivos Therapeutics, Inc. (VVOS) SEC Filings

Everything VVOS has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

41 filings
Date Form Filing
8-K Earnings Release · Other
10-Q
4
4
4
8-K Acquisition Disposition · Delisting · Other Event
8-K Acquisition Disposition · Capital Raise · Dilution · Governance Change · Material Agreement · Other · Other Event · Other Reg Fd · Reg Fd
8-K Acquisition Disposition · Capital Raise · Material Agreement · Other Event · Other Reg Fd · Reg Fd
8-K Auditor Change
4
4
4
8-K/A Capital Raise · Dilution · Material Agreement
8-K Capital Raise · Dilution · Material Agreement
SCHEDULE 13G/A
4
8-K Other Reg Fd · Reg Fd
10-Q
4
10-Q
10-K
4
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-K/A
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q/A
10-Q
10-K
10-Q

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.